A new study has drawn attention to inaccurate measurement of LDL-cholesterol levels in some patients with current assays, which could lead to incorrect therapeutic approaches. The patient groups most ...

I'm a cardiologist. Here are the most important new guidelines that younger people need to know about when it comes to their heart health. Physicians are now urging younger adults to get screened for ...

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) announced Wedensday that the Tina-quant lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. Food and Drug ...

Doctors and researchers discussed new broader testing guidelines and changing treatment practices for those with high Lp(a) ...

Cardiologists highlight Lipoprotein(a), or Lp(a), a blood component that silently increases heart attack and stroke risk.

Muvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 KRAKEN trial show. Concentrations of Lp(a) cholesterol are ...

A new study finds that elevated levels of Lp(a) may increase the risk of death from cardiovascular disease in some patie ...